Clinical Trial Update: Evaluating a New Peptide Therapy for Retinal Diseases: AMD, Diabetic Retinopathy, and Dystrophies [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating an experimental peptide therapy for retinal diseases. The study covers Retinitis Pigmentosa, Age-related Macular Degene…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Diabetic Retinopathy
• Retinitis Pigmentosa

Drugs mentioned

• Peptide therapy for retinal diseases (experimental)

Snippet

Sponsor: Ace Cells Lab Limited | Conditions: Retinitis Pigmentosa (RP), Age Related Macular Degeneration | Phase 1, Phase 2 | Status: RECRUITING